Skip to content

The safety and efficacy evaluation of different material in rhinoplasty

The safety and efficacy evaluation of different material in rhinoplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017431
Enrollment
Unknown
Registered
2018-07-30
Start date
2018-07-15
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

saddle nose

Interventions

costal cartilage group:costal cartilage rhinoplasty
implant group:implant rhinoplasty
injection group:injetion rhinoplasty
costal cartilage and implant group:combined rhinoplasty

Sponsors

Plastic Surgery Hospital, CAMS & PUMC
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) conform the diagnosis of saddle nose, deviated nose, hump nose and short nose; 2) adopt rhinoplasty or secondary rhinoplasty on his/her own will; 3) aged between 18 to 60 years; 4) fully informed this clinical trial, and willingly sign the inform consent.

Exclusion criteria

Exclusion criteria: 1) under severe underlying diseases, such as cardiovascular system, respiratory system, urinary system, digestive system, endocrine system or nervous system which are not suitable for clinical trials; 2) serious systemic diseases, such as immune diseases, abnormal coagulation function, infection, etc.; 3) pregnancy women; 4) tumor history.

Design outcomes

Primary

MeasureTime frame
complication incidence;

Secondary

MeasureTime frame
nasal volume change ratio;patient satisfaction scale;

Countries

China

Contacts

Public ContactZhan-Qiang LI

Plastic Surgery Hospital, CAMS & PUMC

leezhanqiang@hotmail.com+86 13811498686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026